Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$2.79M
60K shares
What this filing means
KAKKIS EMIL D plans to sell 60K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $2.79M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/7/2024ACC: 0002007317-24-000082
DirectorOfficer· President & CEO
Since Mar 2026
60K
Shares to sell
$2.79M
Approx. market value
30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months7
RSU VESTING
CASH
3/1/2022
16.82KRSU VESTING
CASH
10/14/2021
865.00RSU VESTING
CASH
10/14/2020
865.00RSU VESTING
CASH
6/1/2020
1.34KRSU VESTING
CASH
5/6/2020
865.00RSU VESTING
CASH
4/20/2020
864.00RSU VESTING
CASH
3/2/2020
8.38KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2022 | RSU VESTING CASH | 16.82K | — |
10/14/2021 | RSU VESTING CASH | 865.00 | — |
10/14/2020 | RSU VESTING CASH | 865.00 | — |
6/1/2020 | RSU VESTING CASH | 1.34K | — |
5/6/2020 | RSU VESTING CASH | 865.00 | — |
4/20/2020 | RSU VESTING CASH | 864.00 | — |
3/2/2020 | RSU VESTING CASH | 8.38K | — |
| Total | 30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
30K
Market value
$1.44M
12/29/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$1.35M
2/7/2024
Total
Units
60K
Value
$2.79M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/29/2023 | 30K | $1.44M | — | Completed |
| Planned — Approximate Date | ||||
2/7/2024 | 30K | $1.35M | NASDAQ | Planned |
| Total | 60K | $2.79M | ||